“This is also an example of repurposing a safe, inexpensive, and globally available drug and it stresses the importance of genomic testing in colorectal cancer patients.” In Group A, the three-year ...

However, even with this treatment, about two-thirds of patients experience a cancer recurrence and have limited options if the disease returns. “Patients with stage III or IV kidney cancer are ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

Cervical cancer remains one of the most challenging diseases in oncology, with high recurrence rates and significant treatment side effects. For decades, the standard approach has relied on a ...

Exposure to high-normal, compared with low-normal, TSH levels was not associated with an elevated risk for differentiated thyroid cancer recurrence after thyroidectomy. Exposure to high-normal ...

Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

vghtpe.gov.tw Objective: Resection is the best treatment for patients with stage I non-small cell lung cancer ... recurrence survival and their predictors were analysed. Results: The patterns of local ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations ...

They can make cancers more aggressive and harder to treat. The results of this study could immediately change treatment for those colon cancer patients, researchers said. “Aspirin has been shown to ...

Breast Cancer: Fear of Recurrence Can Haunt Women for Years By Ernie Mundell HealthDay Reporter MONDAY, Feb. 10, 2025 (HealthDay News) -- A survey of hundreds of breast cancer survivors finds that ...

Patients in Group A had a 51% lower risk of cancer recurrence when compared to placebo. The rate of recurrence in this group was 7.7% in patients who took aspirin and 14.1% for those who took a ...